[Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate]

Radosław Grabysa1, Marian Cholewa

  • 1Szpital Wojskowy w Olsztynie, Oddział Chorób Wewnetrznych. rgraby@wp.pl

Insights

Chronic kidney disease (CKD) affects nearly half of patients with arterial hypertension (AH), increasing their risk for left ventricular hypertrophy (LVH). Reduced estimated glomerular filtration rate (eGFR) is a key indicator for LVH in AH patients.

Area of Science:

  • Cardiology
  • Nephrology
  • Hypertension Management

Context:

  • Current hypertension guidelines emphasize subclinical organ damage.
  • Renal function impairment and left ventricular hypertrophy (LVH) impact cardiovascular prognosis in arterial hypertension (AH).

Purpose:

  • To assess LVH prevalence in hypertensive patients with diminished renal function.
  • To evaluate the relationship between reduced estimated glomerular filtration rate (eGFR) and LVH using echocardiography (ECHO).

Summary:

  • The study analyzed 749 hypertensive patients, defining chronic kidney disease (CKD) as eGFR < 60 ml/min/1.73 m2.
  • LVH was diagnosed via ECG and ECHO. 42% had CKD, and 48.8% showed LVH by ECHO.
  • CKD patients exhibited a higher mean left ventricle mass index (LVMI) and worse cardiovascular profiles.

Impact:

  • CKD is prevalent in AH patients, associated with poorer cardiovascular outcomes.
  • Reduced eGFR (< 60 ml/min/1.73 m2) significantly increases the odds for LVH diagnosis via ECHO.
  • eGFR serves as a valuable parameter for identifying AH patients who may benefit from ECHO screening.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...